The APS has begun to explore ways in which we can more closely cooperate with the US Environmental Protection Agency, in particular, to provide the agency with objective, science-based information for risk assessments on crop protection chemicals and biotechnology products to ensure their continued availability for combating crop diseases.
2011PPB met with key officials at the EPA to discuss a variety of issues that affect the practice of plant pathology. Key questions covered endocrine disruptor screening program as it relates specifically to the continued availability of important fungicides, how the endangered species act (ESA) implementation changes will affect fungicide use, and how a regional limitation under the ESA on chlorothanonil may have far-reaching implications for important plant health products. Other topics included pesticide drift labeling regulations, national pollutant discharge elimination system for the application of pesticides, and the use of fungicides to promote plant physiological benefits. The PPB and EPA are exploring co-sponsoring a regulatory issues symposium at the 2012 annual meeting. Frank Wong is now serving at the APS-PPB Subject Matter Expert working with EPA, and is taking the lead on developing a fungicide resistance symposium. Topic Discussion Overview
2010PPB met with EPA representatives on potential collaboration points, including the potential for an APS Fellow at EPA headquarters.
2009During PPB's visit to EPA in 2009, the use of fungicides to promote plant physiological benefits in crops was identified as a hot topic that could benefit from further review and discussion. As a result, PPB organized a Hot Topic Symposium during the APS Annual Meeting in Portland, Oregon. Hot Topic WebcastsWhitepaper Overview
2008In November, a first-ever roundtable session was held with EPA in DC to identify opportunities for APS to assist EPA in fulfilling its need for science based data, outreach, and education. EPA Roundtable Presentations
Get ALL the Latest Updates for ICPP2018: PLANT HEALTH IN A GLOBAL ECONOMY. Follow APS!